¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"steroid purpura"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã½ºÀÚ»ö¹Ýº´
  • drug-induced purpura
    ¾à¹°À¯¹ßÀÚ»ö¹Ý
  • dysproteinemic purpura
    ÀÌ»ó´Ü¹éÇ÷ÀÚ»ö¹Ý
  • factitious purpura
    ÀΰøÀÚ»ö¹Ý
  • flat purpura
    ÆíÆòÀÚ»ö¹Ý
  • fulminans purpura
    Àü°ÝÀÚ»ö¹Ýº´, µ¹¹ßÀÚ»ö¹Ýº´
  • gangrenous purpura
    ±«ÀúÀÚ»ö¹Ý
  • hyperglobulinemic purpura
    °í±Û·ÎºÒ¸°Ç÷ÀÚ»ö¹Ý
  • hemorrhagic purpura
    ÃâÇ÷ÀÚ»ö¹Ý
  • Henoch-Schonlein purpura
    Çì³ëÈå-¼é¶óÀÎÀÚ»ö¹Ý
  • Henoch-Schonlein purpura nephritis
    Çì³ëÈå-¼é¶óÀÎÀÚ»ö¹ÝÄáÆÏ¿°, Çì³ëÈå-¼é¶óÀÎÀÚ»ö¹Ý½ÅÀå¿°
  • itching purpura
    °¡·Á¿òÀÚ(»ö)¹Ý
  • immune thrombocytopenic purpura
    ¸é¿ª¼ºÀúÇ÷¼ÒÆÇÀÚ(»ö)¹Ý
  • idiopathic thrombocytopenic purpura
    Ư¹ßÀúÇ÷¼ÒÆÇÀÚ»ö¹Ýº´
  • necrotic purpura
    ±«»çÀÚ»ö¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bullous purpura
    ¼öÆ÷ÀÚ»ö¹Ý, ¹°ÁýÀÚ»ö¹Ý
  • drug-induced purpura
    ¾à¹°À¯¹ßÀÚ»ö¹Ý
  • dysproteinemic purpura
    ÀÌ»ó´Ü¹éÇ÷ÀÚ»ö¹Ý
  • factitious purpura
    ÀΰøÀÚ»ö¹Ý
  • flat purpura
    ÆíÆòÀÚ»ö¹Ý
  • fulminant purpura
    Àü°ÝÀÚ»ö¹Ý
  • gangrenous purpura
    ±«ÀúÀÚ»ö¹Ý
  • hemorrhagic purpura
    ÃâÇ÷ÀÚ»ö¹Ý
  • hyperglobulinemic purpura
    °í±Û·ÎºÒ¸°Ç÷ÀÚ»ö¹Ý
  • idiopathic thrombocytopenic purpura
    Ư¹ßÇ÷¼ÒÆÇ°¨¼ÒÀÚ»ö¹Ýº´
  • itching purpura
    °¡·Á¿îÀÚ»ö¹Ý
  • necrotic purpura
    ±«»çÀÚ»ö¹Ý
  • neonatal purpura
    ½Å»ý¾ÆÀÚ»ö¹Ý
  • obstructive purpura
    Æó¼âÀÚ»ö¹Ý
  • orthostatic purpura
    ±â¸³ÀÚ»ö¹Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypergammaglobulinemic purpura
    °ú°¨¸¶±Û·ÎºÒ¸°Ç÷¼º ÀÚ¹Ý(º´)
  • hyperglobulinemic purpura
    °ú±Û·ÎºÒ¸°Ç÷¼º ÀÚ¹Ý(º´)
  • hypersplenic purpura
    ºñ±â´ÉÇ×Áø¼º ÀÚ¹Ý(Áõ).
  • idiopathic thrombocytopenic purpura
    Ư¹ß¼ºÇ÷¼ÒÆÇ°¨¼Ò¼ºÀڹݺ´(¡­úìá³÷ùÊõá´àõí¹ÚèÜ»)
  • idiopathic thrombocytopenic purpura =ITP
    Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º Àڹݺ´.
  • idopathic thrombocytopenic purpura
    Ư¹ß¼º Ç÷¼ÒÆÇ°¨¼Ò¼º ÀÚ¹ÝÁõ
  • immunologic thrombocytopenic purpura
    ¸é¿ª¼º Ç÷¼ÒÆÇ°¨¼Ò¼º ÀÚ¹Ý
  • post transfusion purpura
    ¼öÇ÷ÈÄÀÚ¹ÝÁõ(âÃúìý­í¹Úèñø)
  • posttransfusion purpura
    ¼öÇ÷ÈÄÀÚ¹ÝÁõ.
  • posttransfusion purpura
    ¼ö¼úÈÄÀÚ¹Ý(â¢âúý­í¹Úè)
  • posttransfusion purpura=PTP
    ¼öÇ÷ÈÄ ÀÚ¹ÝÁõ
  • psychogenic purpura
    ½ÉÀμºÀÚ¹Ý
  • purpura
    ÀÚ¹Ý(í¹Úè)
  • purpura
    ÀÚ¹ÝÁõ
  • purpura allergica
    ¾Ë·¯Áö¼º ÀÚ¹Ý(¡­àõí¹Úè).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • steroid myopathy
    ½ºÅ×·ÎÀ̵å±Ùº´Áõ(¡­Ü»ñø)
  • steroid psychosis
    ½ºÅ×·ÎÀ̵å Á¤½ÅÁõ(º´).
  • steroid rebound phenomenon
    ½ºÅ×·ÎÀÌµå ¹ÝµµÇö»ó(¡­ÚãÔ¯úÞßÚ).
  • steroid sulfatase deficiency
    ½ºÅ×·ÎÀ̵弳ÆÄÅ×À̽º°áÇÌ(Áõ)(¡­ÌÀù¹(ñø))
  • steroid-induced atrophy
    ½ºÅ×·ÎÀ̵å À§Ãà
  • steroid-induced disorders
    ½ºÅ×·ÎÀ̵å À¯¹ßÀå¾Ö(º´).
  • steroid-induced glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
  • steroid-related disorders
    ½ºÅ×·ÎÀÌµå °ü·ÃÀå¾Ö(º´).
  • allergic purpura
    ¾Ë·¹¸£±â(¼º) ÀÚ¹ÝÁõ(í¹Úèñø)
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã¾ç Àڹݺ´(¡­í¹ÚèÜ»).
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã¾ç Àڹݺ´(¡­í¹ÚèÜ»)
  • angioneurotic purpura
    Ç÷°ü½Å°æ¼º Àڹݺ´(¡­í¹ÚèÜ»).
  • annularis telangiectodes purpura
    ¸ð¼¼Ç÷°ü È®À强 ȯ»óÀÚ¹Ý
  • athrombocytopenic purpura
    Ç÷¼ÒÆÇºñ°¨¼Ò¼º ÀÚ¹ÝÁõ(úìá³÷ùÞªÊõá´àõí¹Úèñø).
  • athrombocytopenic purpura
    Ç÷¼ÒÆÇºñ°¨¼Ò¼º Àڹݺ´(úìá³÷ùÞªÊõá´àõí¹ÚèÜ»)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TTP Thrombotic Thrombocytopenic Purpura
AITP autoimmune idiopathic thrombocytopenic purpura
ATP adenosine triphosphate; ambient temperature and pressure; autoimmune thrombocytopenic purpura
CPP cancer proneness phenotype; canine pancreatic polypeptide; cerebral perfusion pressure; chest pain p...
HGP hepatic glucose production; hyperglobulinemic purpura
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ITP Immune thrombocytopenic purpura
PTP Post transfusion purpura
SHP Scholein-Henoch purpura
TTP Thrombotic Thrombocytopenic Purpura
TTP-HUS Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neonatal purpura fulminans
    Àü°Ý¼º ½Å»ý¾Æ ÀÚ¹Ý
  • nonthrombocytopenic purpura
    ºñÇ÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹ÝÁõ
  • purpura
    ÀÚ¹Ý, Àڹݺ´, ÀÚ¹ÝÁõ
    Àá»ó ÃâÇ÷°ú Á¡»ó ÃâÇ÷À» ÇÕÇÑ º´º¯. Àü½ÅÀÇ ÇÇÇϳª Á¡¸·¿¡ ÃâÇ÷ÀÌ ÀϾ¼­ ÀÚ»öÀÇ ÀÛÀº ¹ÝÁ¡ÀÌ »ý±â´Â º´. ÀÚ¹ÝÀº Á¡»ó ÃâÇ÷ ¹Ý ¶Ç´Â ÇÇÇÏ ÀÏÇ÷ ¹ÝÀ¸·Î¼­, »õ·Î »ý±ä °ÍÀº ºÓÀº »öÀ» ¶ì°í, ½Ã°£ÀÇ °æ°ú¿Í ÇÔ²² ´Ù°¥»ö¿¡¼­ Ȳ»öÀ¸·Î º¯Çذ¡´Â °Íµµ ÀÖ´Ù. ÃâÇ÷¼º ¼ÒÀÎ Áß ÁÖ·Î Ç÷°ü º®ÀÇ ÀÌ»ó¿¡ ÀÇÇÑ °Í°ú Ç÷¼ÒÆÇÀÇ °¨¼Ò¿¡ ÀÇÇÑ °ÍÀÌ Àڹݺ´ÀÇ ÇüŸ¦ ÃëÇÑ´Ù. ©ç Ç÷°üº®ÀÇ ÀÌ»ó : ´Ü¼ø¼º Àڹݺ´À̳ª ±â°èÀû Àڱؿ¡ ÀÇÇÑ Àڹݺ´Àº Ưº°ÇÑ Ä¡·á¸¦ ÇÏÁö ¾Ê¾Æµµ ÀÚ¿¬È÷ ¼Ò½ÇµÇ´Â °ÍÀÌ ¸¹´Ù. Ä¡·áÀÇ Çʿ䰡 ÀÖ´Â ´ëÇ¥ÀûÀÎ °ÍÀº ¼é¶óÀÎ-Çì³ëÈå Àڹݺ´À¸·Î¼­, ¾Æ³ªÇʶô½Ã Àڹݺ´ ¶Ç´Â ¾Ë·¹¸£±â¼º Àڹݺ´À̶ó°íµµ ÇÏ´Â ÀÏÁ¾ÀÇ ¾Ë·¹¸£±â¼º ÁúȯÀÌ´Ù. µ¶¹° Áßµ¶, °¨¿°Áõ, ´ç´¢º´, ¿äµ¶Áõ µîÀÌ ¿øÀÎÀÌ µÇ´Â ¼ö°¡ ¸¹¾Æ ÀÌµé ¿øÀÎÁúȯÀÇ Ä¡·á°¡ ÁÖ°¡ µÇ´Â °æ¿ìµµ ÀÖ´Ù. ÇǺο¡ »ý±â´Â °ÍÀ» ¼é¶óÀÎ ÀÚ¹Ý, ¼ÒÈ­±âÀÇ Á¡¸·¿¡ »ý±â´Â °ÍÀ» Çì³ëÈå ÀÚ¹ÝÀ̶ó°í ÇÑ´Ù. ÀüÀÚ´Â ¾ÈÁ¤À» ÃëÇϸé ÀÚ¹ÝÀÇ ÃâÇöÀÌ Àû¾îÁö°í, ¹æÄ¡ÇÏ¿©µµ ÀÚ¿¬È÷ ¼Ò½ÇµÈ´Ù. ÈÄÀÚÀÇ °æ¿ì´Â ½ÉÇÑ º¹Åë ¿Ü¿¡ °üÀý¿°, ½Å°æÅë, ±ÙÀ°Åë, ½ÅÃâÇ÷ µîÀ» ÀÏÀ¸Å°°Å³ª Ç÷º¯ÀÌ ¹èÃâµÇ´Â ¼öµµ ÀÖÀ¸¹Ç·Î ±Þ¼º º¹¸·¿°, Ãæ¼ö¿°, ÀåÆó»ö µî°ú È¥µ¿µÇ±â ½±´Ù. º¸Åë µ¿½Ã¿¡ ³ªÅ¸³ª´Â ÀÏÀÌ ¸¹Áö¸¸, ´Üµ¶À¸·Î ³ªÅ¸³ª´Â ¼öµµ ÀÖ´Ù. Ä¡·á¾àÀ¸·Î¼­´Â ºÎ½Å ÇÇÁú ½ºÅ×·ÎÀ̵å
  • purpura allergica
    ¾Ë·¯Áö¼º ÀÚ¹Ý
  • purpura benign
    ¾ç¼º ÀÚ¹ÝÁõ
  • purpura erythematosa
    È«¹Ý¼º ÀÚ¹Ý
  • purpura hemorrhagica
    ÃâÇ÷¼º ÀÚ¹Ý
  • thrombasthenic purpura
    Ç÷¼ÒÆÇ Ãë¾à¼º Àڹݺ´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
purpura, henoch-schonlein HSP is a form of blood vessel inflammation, a vasculitis that affects small arterial vessels in the skin (capillaries) and the kidneys. Hsp results in skin rash associated with joint inflammation (arthritis) and cramping pain in the abdomen. Hsp frequently follows a bacterial or viral infection of the throat or breathing passages and is an unusual reaction of the body's immune system to this infection. Hsp occurs most commonly in children. Hsp is generally a mild illness that resolves spontaneously, but sometimes it can cause serious problems in the kidneys and bowels. Treatment is directed toward the most significant area of involvement. Joint pain can be relieved by antiinflammatory medications, such as aspirin or ibuprofen. Some patients can require cortisone-related medications, such as prednisone, especially those with significant abdominal pain or kidney disease. Also known as anaphylactoid purpura.
(12 Dec 1998)
purpura, hyperglobulinaemic Purpura associated with an increase in gamma-globulins. The condition is no longer considered a specific entity since the clinical and laboratory findings are observed in a variety of haematologic conditions.
(12 Dec 1998)
purpura iodica Iodic purpura, an eruption of discrete miliary petechiae, usually confined to the lower extremities, appearing in rare instances on administration of any of the iodides.
(05 Mar 2000)
purpura nervosa <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
purpura pulicans Purpura pulicosa, petechiae caused by the bites of insects and animal parasites.
(05 Mar 2000)
purpura rheumatica <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
purpura, schoenlein-henoch A form of nonthrombocytopenic purpura due to a hypersensitivity vasculitis (vasculitis, hypersensitivity) associated with a variety of clinical symptoms including urticaria and erythema, arthropathy and arthritis, gastrointestinal symptoms, and renal involvement.
(12 Dec 1998)
purpura senilis The occurrence of petechiae and ecchymoses on the atrophic skin of the legs in aged and debilitated subjects.
(05 Mar 2000)
purpura simplex The eruption of petechiae or larger ecchymoses, usually unaccompanied by constitutional symptoms and not associated with systemic illness.
Synonym: nonthrombocytopenic purpura.
(05 Mar 2000)
purpura symptomatica A petechial eruption in scarlet fever and other exanthemas.
(05 Mar 2000)
purpura, thrombocytopenic Any form of purpura in which the platelet count is decreased. Many forms are thought to be caused by immunological mechanisms.
(12 Dec 1998)
purpura, thrombocytopenic, idiopathic Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IgG autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.
(12 Dec 1998)
purpura, thrombotic thrombocytopenic A disease characterised by thrombocytopenia, haemolytic anaemia, bizarre neurological manifestations, azotemia, fever, and thromboses in terminal arterioles and capillaries.
(12 Dec 1998)
purpura urticans Purpura simplex accompanied by an urticarial eruption.
(05 Mar 2000)
hyperglobulinaemic purpura <haematology> A condition characterised by proliferation of cells resembling lymphocytes or plasma cells in the bone marrow, anaemia, increased sedimentation rate and hyperglobulinaemia. Physical findings include mucosal bleeding, skin purpura and enlargement of the lymph nodes, liver and spleen.
Origin: Gr. Haima = blood
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á